Surprisingly, F1 and Rh1 can significantly restore VEGF- or Csn-B-induced vascular leakage, suggesting that F1 and Rh1 specifically inhibit NR4A1, which can be an effective therapeutic candidate for blocking vascular leakage in ischemic disease and cancer. Here, NR4A1 is linked to cancer.